The characterisation and determinants of quality of life in ANCA associated vasculitis

Annals of the Rheumatic Diseases

Volumn 73, Issue 1, 2014, Pages 207-211

  Basu, Neil ^a   McClean, Andrew ^b   Harper, Lorraine ^b   Amft, Esther Nicole ^c   Dhaun, Neeraj ^d   Luqmani, Raashid A ^e   Little, Mark A ^f   Jayne, David R W ^g   Flossmann, Oliver ^h   McLaren, John ⁱ   Kumar, Vinod ^j   Erwig, Lars P ^a   Reid, David M ^a   Jones, Gareth T ^a   Macfarlane, Gary J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f TRINITY COLLEGE DUBLIN   (Ireland)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

ⁱ NHS FIFE   (United Kingdom)

^j NINEWELLS HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CASE CONTROL STUDY; CHRONIC DISEASE; DEPRESSION; DISEASE ASSOCIATION; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE;

GRANULOMATOSIS WITH POLYANGIITIS; OUTCOMES RESEARCH; SYSTEMIC VASCULITIS;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANXIETY; CASE-CONTROL STUDIES; CHRONIC DISEASE; DEPRESSION; FATIGUE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SLEEP DISORDERS;

EID: 84889685980     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202750     Document Type: Article

References (33)

1. Koutantji M, Harrold E, Lane SE, et al. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis. Arthritis Rheum-Arthritis Care Res 2003;49:826-37. (Pubitemid 37523636)
2. Basu N, Jones GT, Fluck N, et al. Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 2010;49:1383-90.
3. Faurschou M, Sigaard L, Bjorner JB, et al. Impaired health-related quality of life in patients treated for Wegener's granulomatosis. J Rheumatol 2010;37:2081-5.
4. Tomasson G, Boers M, Walsh M, et al. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken) 2012;64:273-9.
5. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007;66:222-7. (Pubitemid 46226058)
6. Basu N, Swafe L, Reid D, et al. The evaluation of a novel general population sampling frame: an online solution for a persisting problem? J Epidemiol Community Health 2011;65:A175-6.
7. Herlyn K, Reinhold-Keller E, Zeidler A, et al. Health-related quality of life in primary systemic vasculitides. Arthritis Rheum 1998;41:S122-2.
8. Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes 2003;1:29.
9. Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 1988;41:313-21. (Pubitemid 18089231)
10. Deodhar A, Braun J, Inman RD, et al. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Care Res (Hoboken) 2010;62:1266-71.
11. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53. (Pubitemid 23128452)
12. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997;4:92-100. (Pubitemid 127532310)
13. Campos RP, Vazquez MI. Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated. Clin Rheumatol 2012;31:347-55.
14. Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis 2009;68:1827-32.
15. Exley A, Banbury P, Carruthers D, et al. The Vasculitis Damage Index (Vdi). Arthritis Rheum 1995;38:1124-4.
16. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51. (Pubitemid 24361532)
17. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70. (Pubitemid 29135798)
18. Kirkwood BR, Sterne JAC, Kirkwood BR. Eoms Essential medical statistics. Malden, Mass. Oxford: Blackwell Science, 2003.
19. Walsh M, Mukhtyar C, Mahr A, et al. Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res 2011;63:1055-61.
20. Suppiah R, Hadden RD, Batra R, et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 2011;50:2214-22.
21. Tomasson G, Boers M, Walsh M, et al. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res 2012;64:273-9.
22. Koutantji M, Pearce S, Harrold E. Psychological aspects of vasculitis. Rheumatology 2000;39:1173-9.
23. NICE. Guidance on the use of zaleplon, zolpidem and zopiclone for the short term management of insominia. 2004. http://www.nice.org.uk/nicemedia/live/ 11530/ 32845/32845.pdf (accessed Dec 2012).
24. NICE. Anxiety (amended). Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. 2007. http://www.nice.org.uk/nicemedia/live/13314/ 52601/52601.pdf (accessed Dec 2012).
25. NICE. Depression: management of depression in primary and secondary care - NICE guidance. 2004.
26. Rinaldi S, Ghisi M, Iaccarino L, et al. Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 2006;55:427-33. (Pubitemid 43887029)
27. Neill J, Belan I, Ried K. Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs 2006;56:617-35. (Pubitemid 44800261)
28. Sandstrom MJ, Keefe FJ. Self-management of fibromyalgia: the role of formal coping skills training and physical exercise training programs. Arthritis Care Res 1998;11:432-47. (Pubitemid 29020949)
29. Herlyn K, Hellmich B, Seo P, et al. Patient-reported outcome assessment in vasculitis provides important data and a unique perspective. Arthritis Care Res (Hoboken) 2010;62:1639-45.
30. Fayers PM D. Quality of life: the assessment, analysis and interpretation of patient-reported outcomes, 2nd edn. Chichester, UK: Wiley, 2007:566.
31. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol 2007;17:643-53. (Pubitemid 47268775)
32. Grotzinger KM, Stuart BC, Ahern F. Assessment and control of nonresponse bias in a survey of medicine use by the elderly. Med Care 1994;32:989-1003.
33. Norton MC, Breitner JC, Welsh KA, et al. Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc 1994;42:1252-6. (Pubitemid 24377526)